NEW YORK, Nov. 29 (GenomeWeb News) - Cepheid has licensed DxS' real-time PCR technology for use in the human in vitro diagnostics market, the company said today.
...and receive Daily News bulletins.
Already have an account?Login Now.
23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.
In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.
Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.
The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.
